John C. Martin

2012 - Gilead Sciences

In 2012, John C. Martin earned a total compensation of $15.3M as Chairman and Chief Executive Officer at Gilead Sciences, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,375,000
Option Awards$5,433,431
Salary$1,494,214
Stock Awards$4,947,127
Other$7,500
Total$15,257,272

Martin received $5.4M in option awards, accounting for 36% of the total pay in 2012.

Martin also received $3.4M in non-equity incentive plan, $1.5M in salary, $4.9M in stock awards and $7.5K in other compensation.

Rankings

In 2012, John C. Martin's compensation ranked 179th out of 11,487 executives tracked by ExecPay. In other words, Martin earned more than 98.4% of executives.

ClassificationRankingPercentile
All
179
out of 11,487
98th
Division
Manufacturing
70
out of 4,253
98th
Major group
Chemicals And Allied Products
14
out of 1,198
99th
Industry group
Drugs
9
out of 920
99th
Industry
Biological Products, Except Diagnostic Substances
2
out of 160
99th
Source: SEC filing on March 27, 2015.

Martin's colleagues

We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2012.

2012

John Milligan

Gilead Sciences

Chief Operating Officer

2012

Norbert Bischofberger

Gilead Sciences

Chief Scientific Officer

2012

Kevin Young

Gilead Sciences

Former Executive Vice President, Commercial Operations

2012

Robin Washington

Gilead Sciences

Chief Financial Officer

You may also like